(European Heart Journal) In heart failure complicated by cardiogenic shock, early intra-aortic balloon pump (IABP ... showed its LDL cholesterol-lowering power in a phase II trial of patients ...

The Altshock-2 trial was conducted to evaluate whether, compared with standard medical therapy, the IABP would help patients with cardiogenic shock caused by heart failure survive and transition ...

Intra-aortic balloon pump did not outperform standard therapy ... new data aim to help clinicians better approach complex cases of heart failure (HF), especially among patients with overlapping ...